Publications by authors named "Gerlof D Valk"

Claim this Profile
P
Primary hypothyroidism after treatment for childhood cancer in the Dutch Childhood Cancer Survivor Study: Hypothyroidism in childhood cancer survivors.
S van der Leij, Jop C Teepen, Leontien C M Kremer, Heleen J H van der Pal, M M van den Heuvel-Eibrink, Gerlof D Valk

Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial adrenalectomy for pheochromocytoma in the multiple endocrine neoplasia type 2 population: Time to reconsider?
Diederik P D Suurd, Medard F M Van den Broek, Charlotte L Viëtor, Tessa M Van Ginhoven, Richard A Feelders, Gerlof D Valk

Surgery· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysis.
Katherine A English, Carolina R C Pieterman, Francesca Marini, Kate E Lines, Thomas Cuny, Gerlof D Valk

Lancet Diabetes Endocrinol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice.
Maria Luisa Brandi, Carolina R C Pieterman, Katherine A English, Kate E Lines, Omair A Shariq, Gerlof D Valk

Lancet Diabetes Endocrinol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating gene expression assay as a diagnostic and prognostic biomarker for pancreatic neuroendocrine tumours in MEN1.
Eline N M van Vliembergen, Mark J C van Treijen, Rachel S van Leeuwaarde, Carolina R C Pieterman, Joanne M de Laat, Gerlof D Valk

J Clin Endocrinol Metab· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1.
Riccardo Ballarò, Amanda R Wasylishen, Carolina R C Pieterman, Courtney Olsen, Ehsan Irajizad, Gerlof D Valk

Cancer Lett· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire study.
Carolina R C Pieterman, Simona Grozinsky-Glasberg, Dermot O'Toole, James R Howe, Valentina Ambrosini, Gerlof D Valk

J Neuroendocrinol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The natural course of cystic pancreatic neuroendocrine tumours in MEN1.
Eline N M van Vliembergen, Carolina R C Pieterman, Annenienke C van de Ven, Arthur J A T Braat, Gerlof D Valk

Endocr Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival and prognostic differences between appendiceal NETs and goblet cell adenocarcinomas.
Kim Dijke, José van den Berg, Koert F D Kuhlmann, Sonja Levy, Gerlof D Valk

Endocr Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres).
Paola Mattiolo, Michele Bevere, Andrea Mafficini, Anna Vera D Verschuur, Martina Calicchia, Gerlof D Valk

Endocr Pathol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of integrin αβ in medullary thyroid carcinoma.
Lisa H de Vries, Lutske Lodewijk, Emma W Pijnappel, Paul J van Diest, Abbey Schepers, Gerlof D Valk

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in checkpoint-inhibitor-induced hypophysitis: mono- versus combination therapy induced hypophysitis.
Stephanie van der Leij, Karijn P M Suijkerbuijk, Medard F M van den Broek, Gerlof D Valk, Jan Willem Dankbaar

Front Endocrinol (Lausanne)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lived experiences of undergoing regular tumor screening in patients with multiple endocrine neoplasia types 1 and 2 (MEN1/MEN2).
Mirthe Jasmijn Klein Haneveld, Gerlof Dirk Valk, Rachel Sara van Leeuwaarde

J Genet Couns· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites.
Talya L Dayton, Nicolas Alcala, Laura Moonen, Lisanne den Hartigh, Veerle Geurts, Gerlof D Valk

Cancer Cell· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Johannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, Ehsan Irajizad, Jody Vykoukal, Gerlof D Valk

J Clin Endocrinol Metab· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs.
Eline N M van Vliembergen, Hidde Eijkelenkamp, Gerlof D Valk, Menno R Vriens, Gert J Meijer

Front Endocrinol (Lausanne)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple Endocrine Neoplasia Type 1 Syndrome.
Anna Vera D Verschuur, Aranxa S M Kok, Folkert H M Morsink, Wendy W J de Leng, Medard F M van den Broek, Gerlof D Valk

Am J Surg Pathol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Status of Surveillance and Nonsurgical Therapy for Small Nonfunctioning Pancreatic Neuroendocrine Tumors.
Dirk-Jan van Beek, Anna Vera D Verschuur, Lodewijk A A Brosens, Gerlof D Valk, Carolina R C Pieterman

Surg Oncol Clin N Am· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifestyle Factors and Development and Natural Course of Gastroenteropancreatic Neuroendocrine Tumors: A Review of the Literature.
Marit Bogaards, Anne M May, Faduma A Hassan, Gerlof D Valk, Rachel S van Leeuwaarde

Neuroendocrinology· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers.
Sonja Levy, James D Arthur, Melissa Banks, Niels F M Kok, Stephen W Fenwick, Gerlof D Valk

Ann Surg Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Outcomes After Adrenalectomy for Primary Aldosteronism - Early is Accurate: Retrospective Cohort Study.
Diederik P D Suurd, Wessel M C M Vorselaars, Dirk-Jan Van Beek, Inne H M Borel Rinkes, Wilko Spiering, Gerlof D Valk

Ann Surg· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance.
Mark J C van Treijen, Catharina M Korse, Wieke H Verbeek, Margot E T Tesselaar, Gerlof D Valk

Endocr Connect· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four decades of experience with carcinoid heart disease: An analysis of 84 patients.
Sonja Levy, Catherina E Korse, Andre C A de Groot, Ronald C A Meijer, Margot E T Tesselaar, Gerlof D Valk

J Neuroendocrinol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice.
Dirk-Jan van Beek, Carolina R C Pieterman, Frank J Wessels, Annenienke C van de Ven, Wouter W de Herder, Gerlof D Valk

Front Endocrinol (Lausanne)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Lebbink et al. Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time Span. 2021, , 5104.
Chantal A Lebbink, Medard F M van den Broek, Annemiek B G Kwast, Joep P M Derikx, Miranda P Dierselhuis, Gerlof D Valk

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis